Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Dietrich

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
European Child & Adolescent Psychiatry|January 22, 2022
First do no harm: use off-label antipsychotic medication in children and adolescents with great cautionPieter J Hoekstra, Andrea Dietrich
European Child & Adolescent Psychiatry|February 5, 2015
Tourette syndrome research in Europe has entered a new era of collaborationPieter J Hoekstra, Andrea Dietrich
European Child & Adolescent Psychiatry|August 8, 2014
Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatmentPieter J Hoekstra, Andrea Dietrich
Pharmazie in Unserer Zeit|April 6, 2006
[Overview of development status and clinical action. Cisplatin and its analogues]Wieland Voigt, Andrea Dietrich, Hans-Joachim Schmoll
Angewandte Chemie (International Ed. in English)|September 30, 2006
The two odors of iron when touched or pickled: (skin) carbonyl compounds and organophosphinesDietmar Glindemann, Andrea Dietrich, Hans-Joachim Staerk, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 12, 2014
Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorderMariken Dinnissen, Andrea Dietrich, Barbara J van den Hoofdakker, et al.
Neuroscience and Biobehavioral Reviews|October 25, 2012
Environmental factors in Tourette syndromePieter J Hoekstra, Andrea Dietrich, Mark J Edwards, et al.
Journal of Medicinal Chemistry|August 25, 2010
4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor modelRainer Schobert, Bernhard Biersack, Andrea Dietrich, et al.
Expert Opinion on Drug Safety|March 10, 2017
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorderAnnabeth P Groenman, Lizanne J S Schweren, Andrea Dietrich, et al.
European Child & Adolescent Psychiatry|January 8, 2025
Correction: Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot studyPaul T Rosenau, Andrea Dietrich, Barbara J van den Hoofdakker, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
European Child & Adolescent Psychiatry|January 22, 2022
First do no harm: use off-label antipsychotic medication in children and adolescents with great cautionPieter J Hoekstra, Andrea Dietrich
European Child & Adolescent Psychiatry|February 5, 2015
Tourette syndrome research in Europe has entered a new era of collaborationPieter J Hoekstra, Andrea Dietrich
European Child & Adolescent Psychiatry|August 8, 2014
Attention-deficit/hyperactivity disorder: seeking the right balance between over- and undertreatmentPieter J Hoekstra, Andrea Dietrich
Pharmazie in Unserer Zeit|April 6, 2006
[Overview of development status and clinical action. Cisplatin and its analogues]Wieland Voigt, Andrea Dietrich, Hans-Joachim Schmoll
Angewandte Chemie (International Ed. in English)|September 30, 2006
The two odors of iron when touched or pickled: (skin) carbonyl compounds and organophosphinesDietmar Glindemann, Andrea Dietrich, Hans-Joachim Staerk, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 12, 2014
Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorderMariken Dinnissen, Andrea Dietrich, Barbara J van den Hoofdakker, et al.
Neuroscience and Biobehavioral Reviews|October 25, 2012
Environmental factors in Tourette syndromePieter J Hoekstra, Andrea Dietrich, Mark J Edwards, et al.
Journal of Medicinal Chemistry|August 25, 2010
4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor modelRainer Schobert, Bernhard Biersack, Andrea Dietrich, et al.
Expert Opinion on Drug Safety|March 10, 2017
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorderAnnabeth P Groenman, Lizanne J S Schweren, Andrea Dietrich, et al.
European Child & Adolescent Psychiatry|January 8, 2025
Correction: Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot studyPaul T Rosenau, Andrea Dietrich, Barbara J van den Hoofdakker, et al.
Pageof 13